Description
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
Product Unit Size | Cost | Quantity | Stock |
---|
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
Cas No. | 1096708-71-2 |
---|---|
Purity | ≥98% |
Formula | C17H12Cl2F3N7O2S |
Formula Wt. | 506.30 |
IUPAC Name | 2-[(1R)-1-[(6-amino-5-chloropyrimidine-4-carbonyl)amino]ethyl]-N-[5- chloro-4-(trifluoromethyl)pyridin-2-yl]-1,3-thiazole-5-carboxamide |
Solubility | DMSO 100 mg/mL (197.51 mM) Ethanol 100 mg/mL (197.51 mM) Water Insoluble |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet | |
Brochures |
http://clinicaltrials.gov/show/NCT01425008
Alkaline phosphatase substrate used to quantify...
HDAC inhibitor. May reduce blood pressure in hy...
NSAID; COX-1/2 and PDE inhibitor.
Synthetic derivative of glycyrrhizin; connexin ...
Triterpene saponin found in species of Panax.
Tamoxifen derivative; potential proteasome inhi...
Minor kavalactone originally found in Piper met...
Triazole; demethylation inhibitor.
Synthesis impurity
Rifampicin derivative; DNA-dependent RNA polyme...
Glycoprotein IIb/IIIa inhibitor.
NSAID; TRPA1 agonist, COX-2 inhibitor.
Recombinant HIV-1 glycoprotein antigen fragment...
Cephalomannine derivative found in Taxus; poten...
Polyether cationic ionophore.
OVA antigen.
TNKS1/2 inhibitor.
HPGDS inhibitor.
Allosteric inhibitor
Diclofenac analog, NSAID; COX-2 inhibitor.